If uric acid levels are high, serum glucose-6-phosphate dehydrogenase (G6PD) level is checked because G6PD deficiency precludes treatment with rasburicase, which is often given to prevent tumor lysis syndrome but may cause hemolytic anemia in patients with G6PD deficiency.